DIA Bioventure Day

Is the current Bioventure paradigm delivering return for patients and investors? This is the key question to be addressed by stakeholders from the funding, and from the innovating side.

Agenda

Day 1 Mar 28, 2017

8:30 AM — 8:50 AM

Welcome remarks

8:50 AM — 9:10 AM

Key Note: Success Factors for Bringing a Product to the Market

9:10 AM — 10:40 AM

Session 1: Health System Financing and Reimbursement of Innovation

11:00 AM — 12:30 PM

Session 2: Innovative Funding Models

12:30 PM — 1:15 PM

EMA Health Care Pipeline White Spots Analysis – Opportunities for BioVentures?

2:00 PM — 3:30 PM

Hepatitis C: Expensive Cure Versus Life-Long Suffering and Health Care Expenses

4:00 PM — 5:30 PM

Immuno-Oncology: Therapeutic Break Through Area or Nightmare for Health Care Funding

5:30 PM — 7:30 PM

Moderated Poster Walk & Networking Reception

Have an account?

DIA Bioventure Day

Agenda

Be informed and stay engaged.